Evidence map›Paper›PMID 35669037›Full record

ReviewNature reviews. Materials2022

Engineering the multiscale complexity of vascular networks.

Colleen O'Connor, Eileen Brady, Ying Zheng, Erika Moore, Kelly R Stevens

Abstract readReview
In one paragraph

Review in Nature reviews. Materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. 4D force patterning enables spatial control of angiogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Colleen O'Connor *Department of Bioengineering, University of Washington, Seattle, WA USA.ORCID 0000-0002-4691-7426
Eileen Brady *Institute for Stem Cell and Regenerative Medicine, Seattle, WA USA.ORCID 0000-0003-2706-9094
Ying ZhengDepartment of Bioengineering, University of Washington, Seattle, WA USA.ORCID 0000-0003-2723-9022
Erika MooreDepartment of Materials Science and Engineering, University of Florida, Gainesville, FL USA.ORCID 0000-0003-2192-6147
Kelly R StevensDepartment of Bioengineering, University of Washington, Seattle, WA USA.ORCID 0000-0002-4024-2990

Funding

University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
Perfusable 3D human cardiac constructs for heart regenerationR01HL141570 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E, ZHENG, YING · 2018 to 2021
$3.3M
Photoabsorbing bioinks for expanding 3D printed human liver in situR01DK128551 · NIDDK · UNIVERSITY OF WASHINGTON · PI STEVENS, KELLY R · 2021 to 2024
$3.0M
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy TestingUG3TR002158 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2018
$2.9M
NCATS NIH HHS UG3 TR002158NHLBI NIH HHS R01 HL141570NIDDK NIH HHS R01 DK128551NIGMS NIH HHS T32 GM007266
6 · The paper itself

Abstract

The survival of vertebrate organisms depends on highly regulated delivery of oxygen and nutrients through vascular networks that pervade nearly all tissues in the body. Dysregulation of these vascular networks is implicated in many common human diseases such as hypertension, coronary artery disease, diabetes and cancer. Therefore, engineers have sought to create vascular networks within engineered tissues for applications such as regenerative therapies, human disease modelling and pharmacological testing. Yet engineering vascular networks has historically remained difficult, owing to both incomplete understanding of vascular structure and technical limitations for vascular fabrication. This Review highlights the materials advances that have enabled transformative progress in vascular engineering by ushering in new tools for both visualizing and building vasculature. New methods such as bioprinting, organoids and microfluidic systems are discussed, which have enabled the fabrication of 3D vascular topologies at a cellular scale with lumen perfusion. These approaches to vascular engineering are categorized into technology-driven and nature-driven approaches. Finally, the remaining knowledge gaps, emerging frontiers and opportunities for this field are highlighted, including the steps required to replicate the multiscale complexity of vascular networks found in nature.

Indexed as

Biological modelsBiomaterialsPreclinical research

Identifiers

PMID35669037
PMCPMC9154041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.